De Simone, P.; Precisi, A.; Lai, Q.; Ducci, J.; Campani, D.; Marchetti, P.; Gitto, S.
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2024, 16, 1243.
https://doi.org/10.3390/cancers16071243
AMA Style
De Simone P, Precisi A, Lai Q, Ducci J, Campani D, Marchetti P, Gitto S.
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers. 2024; 16(7):1243.
https://doi.org/10.3390/cancers16071243
Chicago/Turabian Style
De Simone, Paolo, Arianna Precisi, Quirino Lai, Juri Ducci, Daniela Campani, Piero Marchetti, and Stefano Gitto.
2024. "Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation" Cancers 16, no. 7: 1243.
https://doi.org/10.3390/cancers16071243
APA Style
De Simone, P., Precisi, A., Lai, Q., Ducci, J., Campani, D., Marchetti, P., & Gitto, S.
(2024). Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers, 16(7), 1243.
https://doi.org/10.3390/cancers16071243
